A detailed history of Hussman Strategic Advisors, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 105,000 shares of TGTX stock, worth $3.16 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
105,000
Holding current value
$3.16 Million
% of portfolio
0.64%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$17.21 - $25.28 $1.81 Million - $2.65 Million
105,000 New
105,000 $2.46 Million
Q3 2023

Nov 07, 2023

BUY
$8.36 - $26.5 $438,899 - $1.39 Million
52,500 New
52,500 $438,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.37B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.